Welcome to our dedicated page for RGBAD news (Ticker: RGBAD), a resource for investors and traders seeking the latest updates and insights on RGBAD stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect RGBAD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of RGBAD's position in the market.
Regen BioPharma, Inc. is set to present at the Emerging Growth Conference on March 8, 2023, providing a platform for interactive engagement between the company and investors. The conference will be held from 1:10 PM to 1:20 PM Eastern time. CEO Dr. David Koos will discuss the company's recent reverse stock split, future financing, and programmatic plans. Investors can register for the event to submit questions live. An archived webcast will also be available for those who cannot attend. Regen BioPharma focuses on developing innovative therapies for cancer and autoimmune disorders, emphasizing a robust pre-clinical pipeline.
Regen BioPharma, Inc. invites investors to its live presentation at the Emerging Growth Conference on March 8, 2023.
Date: March 7, 2023, from San Diego. The biotechnology firm, trading as RGBPD and RGBAD, will discuss recent developments, including a reverse stock split and future financing strategies.
Attendees can interact with CEO Dr. David Koos in real-time. The presentation is scheduled for 1:10 - 1:20 PM Eastern Time. Registration is required for participation, and an archived webcast will be available for those unable to attend live.
